Navigation Links
International Isotopes Inc. Names James Mayer as Chief Operating Officer
Date:1/14/2008

IDAHO FALLS, Idaho, Jan. 14 /PRNewswire-FirstCall/ -- International Isotopes Inc. (OTC Bulletin Board: INIS) is pleased to announce the appointment of James Mayer as Chief Operating Officer (COO).

James Mayer joined International Isotopes as Chief Operating Officer on January 11, 2008. Mr. Mayer received his Bachelor of Science in Nuclear Engineering from Texas A & M University and a Masters of Business Administration from the University of Nebraska at Lincoln. He has over 25 years of management experience in the U.S. Navy as well as civilian corporations and he has previously served as Facility Manager, Senior Project Engineer, and Production Manager at a Fortune 500 corporation.

Steve T. Laflin, International Isotopes Inc. President and Chief Executive Officer said, "The Company has not previously had a COO position. However, our rapidly growing manufacturing operations and increasing corporate demands created by additional business opportunities for the Company dictate the need for a dedicated COO. Mr. Mayer has in-depth familiarity with the nuclear industry as well as the commercial sector. He brings with him solid business, management, and operational skills and broad-based experience in manufacturing. He is an outstanding fit to our team and I am certain he will become a valuable asset to the Company as we strive to improve our production efficiencies, reduce operating costs, and incorporate new product lines into the Idaho operations."

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on
'/>"/>

SOURCE International Isotopes Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. International brain aging expert challenges the existence of Alzheimers as a disease
2. EHE International Supports the American Liver Foundations Efforts at Raising Awareness for Hepatitis
3. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
4. International Sports Sciences Associations Ten Best Resolutions for Better Health in 2008
5. Joint Commission International Achieves Accreditation from ISQua
6. International Development Expert to Lead the Pan American Health and Education Foundation
7. Natural Nutrition Launches Long Life Cocktail with International Television Ad Campaign
8. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
9. NEWSWEEK: International Editions: Highlights and Exclusives, Dec. 31, 2007- Jan. 7, 2008
10. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
11. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...irstCall/ -- Heska Corporation,(Nasdaq: HSKA ) ...ciety of,Security Analysts, 12th Annual Biotech a...8 at 1177 Avenue of the Americas, 2nd Floor in New... at 9:35 a.m. Eastern Time (7:35 a.m.,Mountain Ti... two weeks,following the presentation through a l...
(Date:11/21/2008)...technique to combat cancer, study says, , ... researchers have discovered that some cancer cell...his might lead to new treatments that starve and k...all cells in the body need to produce energy. They...t requires oxygen. Compared with normal cells, tum...
(Date:11/21/2008)...Newswire/ -- U.S. News & World Report and the ...nked BlueChoice(R) HealthPlan of South Carolina in... published in U.S. News & World Report,s issue...g ranks the nation,s best health plans based on cl...ditation scores. NCQA and U.S. News & World Re...
(Date:11/21/2008)...ases production of neural stem cells , ,...s in mice, exercise appears to reverse the decline...n with aging, Taiwanese researchers report. , T...to stave off aging appears to be due to exercise,s...ial for the production of new brain cells. , "...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Exercise Keeps the Brain Young 2
...esearchers have found that the body is capable of ... guard against urinary tract infection//. It was t...ansing mechanism, which prevented bacteria from fo...rs at the Department of Microbiology, Tumour and C...
... June 4. Nearly Rs 3.66 crore has been sanctioned ...nwari centres in Jammu and Kashmir's Doda district...ter Haji Nisar Ali said today. A total of 1,010 Aa...e district while 693 more are being set up during ...
...udy has suggested that, engaging in sex during the...our, as it is widely thought to be//. Clearing the...y physical pleasure during the last lap of pregnan...ef. A study was conducted among 93 women, with 50...
... Health Minister Dr Kebede Worku has said that the...on among women in the country. The prevalence rate.../Aids pandemic due to their low socio-economic sta...gical factors,' he said. 'The national surveillanc...
Other Medicine News:
(Date:11/19/2008)...ignificance , , ISELIN, N.J., Nov. 19 /PRN... PARS ) today announced results from its Phase 2...drug delivery technology formulated with 3% Diclof...randomized, double-blinded, placebo-controlled stu...y,s 3% Diclofenac Diethanolamine NanoEmulsion crea...
(Date:11/19/2008)..., MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall...) today announced that it has achieved the enrollm...its lead alpha-7 nicotinic receptor agonist, in co...CIAS). The Company has randomized 212 patients in...ent from its partner Roche. Memory Pharmaceutical...
(Date:11/18/2008)... -- Forty-two leading U. S. scientists and special...ider cutting-edge innovations that may defend Amer...reaks of dangerous zoonotic diseases, the FAZD Cen...tions: , , , , A "Doc in a Box"...ly contagious and dangerous zoonotic diseases in p...
(Date:11/13/2008)...Prior to Surgery, ARLINGTON HEIGHTS, Ill., Nov. 1...ion before surgery in massive weight loss patients...se surgical complications, accelerate,wound healin...evels,according to a study in the December issue ...cial medical journal of the American Society of Pl...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Vertos Medical Inc Presents Clinical Data of its MILD 26amp 3B 238482 3B Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conferenc 24125 1Vertos Medical Inc Presents Clinical Data of its MILD 26amp 3B 238482 3B Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conferenc 24125 2Sunrise Senior Living Founder and CEO to Become Chairman 24121 1Sunrise Senior Living Founder and CEO to Become Chairman 24121 2Sunrise Senior Living Founder and CEO to Become Chairman 24121 3Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast 6594 1Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast 6594 2Sangamo BioSciences Announces Second Quarter Conference Call and Webcast 6591 1Sangamo BioSciences Announces Second Quarter Conference Call and Webcast 6591 2Sangamo BioSciences Announces Second Quarter Conference Call and Webcast 6591 3
...SALEM--(BUSINESS WIRE)--May 17, 2007 - BioLineRx L...t company, announced today,that abstracts containi...inical trails of BL-1020, first in class GABA-enha...nia, have been,accepted for poster presentations a...ill be presented at the following,conferences:, --...
...DIEGO--(BUSINESS WIRE)--May 17, 2007 - Inovio Biom...lopment of DNA-based,vaccines for cancers and infe... to treat localized cancers, announced today,that ...ata from two,phase I clinical trials of plasmid-ba... delivery technology at the Third,International Co...
Other Medicine Technology:BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 2BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 3Inovio Biomedical's Partners to Present New Data from Two Cancer,Immunotherapy Clinical Trials 2Inovio Biomedical's Partners to Present New Data from Two Cancer,Immunotherapy Clinical Trials 3Inovio Biomedical's Partners to Present New Data from Two Cancer,Immunotherapy Clinical Trials 4
...dies have confirmed Atriums superior biocompatibil...rformance in hernia repair. These same studies ind...esh can result in a stronger, less rigid repair. S...polypropylene mesh with its Parallel Flex™ m...
...; Plug is a non-absorbable, lightweight, pre-forme...ows of monofilament polypropylene with multiple pr... simply conforms to the defect, stays in place, su...uring the procedure. The soft, flexible mesh minim...
...g; PLUS Biomaterial is the first hernia repair mat...g potential operative contamination of the materia...timicrobial preservative agents, silver carbonate ...bacterial colonization on the patch for up to 10 d...
The original, and now classic, Bard mesh sheet can be tailored perioperatively and customized to any unique situation. Bard mesh sheets are available in seven convenient sizes.
Medicine Products: